HS Code for Nicotine patches

Nicotine patches are classified under HS code 2404.92, which is specifically designated for products intended for the intake of nicotine into the human body via transdermal application. This classification was established in the 2022 HS nomenclature to provide a clear home for "Next Generation Products" (NGPs) that deliver nicotine without combustion. Transdermal application refers to the delivery of the active substance through the skin and into the bloodstream. These patches are typically composed of a backing layer, a nicotine reservoir or matrix, an adhesive layer, and a protective liner. The classification is driven by the delivery mechanism (transdermal) and the active substance (nicotine). By placing these under Chapter 24, customs authorities can better monitor the trade of nicotine-replacement therapies and distinguish them from both traditional tobacco and general pharmaceutical products.

Products Included

• Nicotine transdermal patches
• Nicotine skin patches for smoking cessation
• Slow-release nicotine dermal delivery systems
• Nicotine-infused adhesive patches

Common Misclassification

A common misclassification for nicotine patches is heading 3005, which covers pharmaceutical goods like wadding, gauze, and bandages. While patches are used for health purposes, the specific nicotine heading 2404.92 is more specific and thus takes precedence. Another error is classifying them under 2404.91, which is reserved for oral application products like pouches. It is also possible to see them misclassified under 3824.99 as chemical mixtures, but the 2022 update to the HS code system specifically created 2404.92 to eliminate this ambiguity and ensure uniform global classification for transdermal nicotine products.

FAQ

What is the HS code for Nicotine patches?

The HS code for nicotine patches intended for transdermal application is 2404.92.

Are nicotine patches considered medicine in the HS code?

While they have therapeutic uses, the Harmonized System classifies them under 2404.92 based on their nicotine content and delivery method, rather than as general medicaments in Chapter 30.